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Voices in the wilderness: how exclusionist article processing 
charge policies of academic journals underscore what is 
wrong with global health
The global health landscape has increasingly come under 
intense scrutiny in the last two years for diverse reasons, 
traceable to its colonial and, by extension, Western-
dominated structure. From the foreign gaze of global 
health research, to the poor diversity in the composition 
of the editorial boards of global health journals, to the 
tendency of high article processing charges (APCs) of 
global health journals that exclude the contribution of 
researchers from low-income countries, these issues 
have been a subject of public discourse.1–3
There is a need for diversity in global health. Who 
tells the stories counts perhaps as much as what 
is being said; a concept that might be an essential 
aspect of the movement to decolonise global health.2 
Currently, scholarly articles are mainly published in peer-
reviewed journals, and they disseminate the results 
of experiments or research projects that have been 
funded through grants that include funds to cover APCs 
in open access journals. In some cases, manuscripts 
might be eligible for an APC waiver to encourage 
scholarly contributions from researchers in low-income 
countries. However, many researchers continue to face 
a double jeopardy of not being externally funded by 
grants and being ineligible for APC waivers to publish 
their self-funded research. It is therefore not surprising 
that only 1·3% of annual global research outputs come 
from Africa, with just three countries (Kenya, Nigeria, 
and South Africa) accounting for 52% of Africa’s 
output.4 In this Commentary, we explore the dilemma 
of such researchers, who we refer to as the voices in the 
wilderness.
In response to The Lancet Global Health’s call for articles 
on what is wrong with global health,5 we reviewed the 
conditions for an APC waiver or discount in 13 major 
global health journals. We decided to look at these 
13 journals by updating the original list of 12 major global 
health journals identified by Nafade and colleagues,3 
which was based on the subgroup of academic journals 
that explicitly had ‘global health’ or ‘international health’ 
as part of the journal title. One author (OW) searched 
the website of each journal and extracted information 
on the journal’s conditions for APC waivers, and this 
information was crosschecked for accuracy by a second 
author (EN). We found that three broad conditions were 
explicitly stated by the 13 journals for authors to qualify 
for an APC waiver or discount. These conditions include 
authors’ affiliations to an institution from a low-income 
or middle-income country (LMIC), being a corresponding 
author from an LMIC, and their availability (or absence 
thereof) of funding.
To capture the range of authorship scenarios, we 
created eight groups based on a combination of the 
three major conditions for APC waivers or discounts. 
The figure shows the conditions for an APC waiver or 
discount for every journal and the group of authors 
who qualify or do not qualify. Two (15%) out of the 
13 journals explicitly offer full APC waivers for all 
authorship scenarios. For most journals, when all the 
authors are from a low-income country (group 1) they 
qualify for a full waiver, whereas when all the authors 
are from an LMIC (group 2) they only qualify for an 
APC discount, irrespective of the availability of funding. 
Articles that included any author from a high-income 
country (group 4) do not qualify for any form of APC 
waiver or discount, and most journals do not offer 
an APC waiver for articles that included authors from 
a combination of low-income countries and LMICs 
(group 3). Four (31%) of the 13 journals explicitly offered 
an APC waiver if the corresponding author is from a low-
income country, and a discount if they are from an LMIC.
From the eight different scenarios in our figure, we 
identify three key implications that these APC policies 
pose to early career researchers from low-income 
countries. First, researchers in low-income countries 
are already faced with many challenges such as scarce 
funding, scarce governmental and institutional 
support for science, and poor infrastructure, which 
substantially hampers their research progress. Having 
to pay high APCs is seen as exacerbating these existing 
challenges.6 Moreover, many of these researchers earn 
too little from their income or meagre research grants 
to consider publishing in such top tier open access 
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journals. With some APCs as high as the annual salaries 
of some scientists in many African countries, these 
scientists cannot publish and therefore miss out on 
the visibility needed to compete in the global health 
research landscape,7 which then puts them at a further 
disadvantage when it comes to competing for research 
funding, thus resulting in a vicious cycle.
Second, the current APC policies hamper the desire 
for collaboration amongst scientists in LMICs. As early 
career researchers ourselves, we recognise the need 
for collaboration with our peers from LMICs. However, 
even though we are based in a low-income country, we 
recognise situations when partnering with our peers 
from LMICs would alter our eligibility for APC waivers 
and put us in a less favourable position. We acknowledge 
that we are privileged simply because we are authors 
living and working in a low-income country as this gives 
us access to APC waivers in some high impact journals. 
Nonetheless, we also recognise that these policies hinder 
our collaboration with peers in LMICs whose voices are 
not heard simply because of geography. We agree with 
Abimbola and colleagues8 that the crude dichotomies 
used by these journals to define who gets an APC 
waiver and who does not, based on country income 
classifications, might be obscuring more than they 
reveal. Such policies continue to perpetuate the serious 
asymmetry of power and privilege, and the global health 
voices that are heard are not truly representative of the 
so-called global south.
Lastly, these exclusionist APC policies perpetuate 
the already deeply entrenched imbalance in who tells 
the story in academic global health. The apparent 
underrepresentation of authors from low-income 
countries and LMICs who contribute to articles in 
mainstream global health journals will continue to tilt the 
power imbalance, and underscores what is wrong with 
global health.5,9 Even when scientists from low-income 
countries and LMICs appear in these journals, they are 
mostly already established researchers who can afford 
an APC, or if they are early career researchers, they are 
usually stuck somewhere in the middle of the author list, 
flanked at both ends by prominent collaborators from 
high-income countries.10 As these early career researchers 
from LMICs rarely attain prominent authorship roles, 
they will continue to miss opportunities to contribute 
meaningfully to the global health discourse.5,11
As early career researchers from a low-income country, 
we consider ourselves as lucky simply because of our 
location, a luxury that many of our peers who are doing 
good quality research in LMICs cannot afford. These 
voices in the wilderness who make up a large proportion 
of early career researchers from low-income countries 
and LMICs will continue to be unheard as they have 
neither the funding from research grants, the luck of 
Figure: The conditions for article processing charge waivers or discounts in 13 major global health journals
Information on the criteria to qualify for a waiver or discount of an APC was extracted from each journal’s website on April 20, 2021. Group 1: all authors are from 
low-income countries. Group 2: all authors are from LMICs. Group 3: authors are from low-income and LMICs. Group 4: authorship is mixed (including low-income, 
LMICs, and high-income countries). Group 5: authorship is mixed but the corresponding author is from a low-income country. Group 6: authorship is mixed but the 
corresponding author is from an LMIC. Group 7: all authors are from low-income countries and have no funding. Group 8: authors are from low-income countries 
and LMICs and have no funding. APC=article publishing charge. LMIC=low-income or middle-income countries. *2019 Journal Impact Factor, Journal Citation Reports 
(Clarivate Analytics 2020). †APC covered by the Global Health Institute, University of Wuhan, China.
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Annals of Global Health 2·037 1365 dollars 
Globalization and Health 2·525 2690 dollars 
BMJ Global Health 4·280 3000 pounds 
Clinical Epidemiology and Global Health 0·708 1200 dollars 
Global Health Action 2·162 1582 dollars 
Global Health Research and Policy NA APC covered† 
Global Health: Science and Practice 2·352 Does not charge any fees 
Global Public Health 1·791 3500 dollars 
International Health 1·664 3164 dollars 
Journal of Epidemiology and Global Health 2·200 975 euros 
Journal of Global Health 2·899 1750 dollars 
The Lancet Global Health 21·597 5000 dollars 
Tropical Medicine & International Health 2·308 3150 dollars 
No explicit comment regarding APC waiver or discount 
Journal explicitly offers a full APC waiver Journal explicitly offers an APC discount Journal states that they might offer an APC waiver or discount 
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geographical location, nor the prominence to allow their 
voices to be heard. As expected, the story will always 
depend on who is telling it.
We expect that the global health research landscape 
should be more equitable and less about luck. But then, 
what is the way forward to achieve this expectation? 
We think that addressing the constraints outlined 
in this Commentary will require a multifaceted 
approach. Since collaboration remains a crucial aspect 
of global health, we advocate that journals include 
an additional eligibility criterion for APC waivers, 
such as for early career researchers without external 
funding, to ensure that the dissemination of good 
quality research is not determined by the ability to 
pay. Additionally, governments and philanthropists in 
low-income countries and LMICs must step up funding 
for global health research, as was done in 2021 by a 
Nigerian billionaire who announced an annual fund of 
US$100 million for development priorities, including 
research.12 This laudable initiative should be encouraged 
and emulated by other billionaires in Africa. If these 
issues are not addressed with urgency, the voices of 
early career researchers from low-income countries and 
LMICs, like those from a wilderness far away, will be lost.
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